Cutaneous manifestations in D-2-hydroxyglutaric aciduria type 2 and response to enasidenib therapy
Jennifer Roux, BS,
Gabrielle Brody, MD,
Brandie Metz, MD,
Jingyun Gao, MD,
Changrui Xiao, MD,
Richard C. Chang, MD
Affiliations
Jennifer Roux, BS
University of California Irvine School of Medicine, Irvine, California; Correspondence to: Jennifer Roux, BS, UC Irvine School of Medicine, 1001 Health Sciences Rd, Irvine, CA 92617.
Gabrielle Brody, MD
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Brandie Metz, MD
Department of Dermatology, Children’s Hospital of Orange County, Orange, California; Pediatric Dermatology of Orange County, Irvine, California
Jingyun Gao, MD
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Changrui Xiao, MD
Department of Neurology, University of California Irvine, Irvine, California; Metabolic Disorders Division, Children’s Hospital of Orange County, Orange, California
Richard C. Chang, MD
Metabolic Disorders Division, Children’s Hospital of Orange County, Orange, California